▾ G11 Media Network: | ChannelCity | ImpresaCity | SecurityOpenLab | GreenCity | Italian Channel Awards | Italian Project Awards | ...
InnovationOpenLab

HTuO Biosciences Joins Johnson & Johnson Innovation - JLABS

#drugdevelopment--HTuO Biosciences, a biotechnology company developing an innovative molecular simulation platform for drug discovery, announces it has joined Johnson & Johnson Innovation - JLABS ...

Business Wire

HTuO Biosciences, a computational drug discovery biotechnology company, is pleased to announce joining Johnson & Johnson Innovation – JLABS

VANCOUVER, British Columbia: #drugdevelopment--HTuO Biosciences, a biotechnology company developing an innovative molecular simulation platform for drug discovery, announces it has joined Johnson & Johnson Innovation - JLABS as a resident virtual company.

HTuO Biosciences aims to revolutionize drug design and optimization with AtomForge, a platform powered by a proprietary physics engine and machine learning. AtomForge will redefine molecular modelling, drug discovery, and approaches to targeting undruggable proteins.

Dr. Anthony Fejes, CEO and co-founder of HTuO Biosciences, remarks:

“We are thrilled to join JLABS as it will provide world-class mentorship, industry connections and research capabilities. Becoming a JLABS member is a testament to our technology, the team, and the strength of the biotechnology sector in British Columbia.”

HTuO Biosciences is a virtual company of Johnson & Johnson Innovation - JLABS, a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-enhancing health and wellness solutions to patients around the world. As a leader in innovation, JLABS helps pharmaceutical, medical technology, and health tech entrepreneurs bring healthcare solutions to patients and consumers. More information: http://jlabs.jnjinnovation.com/

About HTuO

HTuO Biosciences is a computational biotechnology company based in Vancouver, Canada, with the mission of developing advanced molecular simulation software capable of accurately predicting the behaviour of molecules to accelerate drug optimization and expand the range of druggable targets. The core technology, the AtomForge force field, is powered by a novel physics algorithm and utilizes a machine learning approach to go beyond the limits of current computer-aided drug design tools. To learn more, please visit www.htuobio.com.

Fonte: Business Wire

If you liked this article and want to stay up to date with news from InnovationOpenLab.com subscribe to ours Free newsletter.

Related news

Last News

ShopFully goes shopping in Spain (again)

ShopFully, the Italian company leader in Europe in drive-to-store solutions, acquired the Spanish Ofertia.

Sicily is more and more digitally connected

Thanks to EXA Infrastructure investments, more routes provide rapid access to mainland Italy and beyond

Italian startup Audio Innova combines AI and metaverse for art preservation

Audio Innova won the first prize in the "Creative AI" category at WAICF in Cannes

Sparkle expands its international network to Iraq

With a new Point of Presence in Erbil, Sparkle consolidates its positioning as leading global Tier-1 operator

Most read

Sicily is more and more digitally connected

Thanks to EXA Infrastructure investments, more routes provide rapid access to mainland Italy and beyond

ShopFully goes shopping in Spain (again)

ShopFully, the Italian company leader in Europe in drive-to-store solutions, acquired the Spanish Ofertia.

Globalstar, Inc. Earnings Release and Call Notice

Globalstar, Inc. (NYSE American: GSAT) will announce its fourth quarter and annual 2023 financial and operating results on Wednesday, February 28, 2024…

Altimetrik Unveils a Market First Digital Business Methodology

With global spending on digital technologies and AI projected to exceed $3.4 trillion by 2026, the urgency to embrace digital business has never been…

Newsletter signup

Join our mailing list to get weekly updates delivered to your inbox.

Sign me up!